As the major role of Mmp2 is extracellular matrix (ECM) remodeling, reduced Meg3 levels help drive Mmp2 expression therefore reducing fibrosis and myocardial hypertrophy as well as improving diastolic function in a mouse model of TAC. Here, MMP2 is linked to cardiac hypertrophy.